Skip to main content
Clinical Trials/NCT02420002
NCT02420002
Completed
Phase 4

Suture Care in the Pediatric Emergency Department: a Randomized Trial Comparing the Analgesic Efficacy of Hypnosis Versus MEOPA

Centre Hospitalier Universitaire de Nīmes1 site in 1 country60 target enrollmentOctober 25, 2016

Overview

Phase
Phase 4
Intervention
Use of MEOPA during suturing
Conditions
Wounds, Nonpenetrating
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
60
Locations
1
Primary Endpoint
Failure of pain control: yes/no
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

This is a therapeutic, randomized, single center, two parallel-arm trial comparing pain control via "MEOPA" (equimolar mixture of nitrous oxide and oxygen) in one arm versus "Hypnosis + MEOPA if needed" in the second arm.

The primary objective is to compare the two study arms in terms of efficacity for pain control according to the FLACC (Face Legs Activity Cry Consolability Observational Tool) behavioural scale.

Detailed Description

The secondary objectives of this study are to compare the two study arms in terms of: * Efficacity for pain relief during suturing according to other validated scales (a visual analog scale (VAS), the EVENDOL (Evaluation Enfant Douleur) scale); * the duration of the procedure, the time between the start of the care process for pain (hypnosis or nitrous oxide) and the beginning of the suture; * the amount of nitrous oxide administered; * the conditions under which suturing takes place, in terms of (i) the general conditions of implementation, (ii) the need to use physical restraint, (iii) failure of the procedure and the need to resort to supplementary means of anesthesia, (iv) satisfaction of the operator and his/her perceived ease of operations, (v) satisfaction of the parents; * the behavior of the patient during removal of the suture; * the conditions under which suture removal takes place; * complications related to the used treatments.

Registry
clinicaltrials.gov
Start Date
October 25, 2016
End Date
March 24, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient was informed about the implementation of the study, its objectives, constraints and patient rights
  • The legal representative of the patient must have given free and informed consent and signed the consent
  • The patient must be affiliated with or beneficiary of a health insurance plan
  • The patient is available for 15 days of follow-up
  • The patient is consulting in the emergency department for a wound requiring the completion of a suture and for which the operator considers that the use of nitrous oxide is necessary and possible.

Exclusion Criteria

  • The patient is participating in another interventional study
  • The patient has participated in another interventional study in the last 3 months
  • The patient is in an exclusion period determined by a previous study
  • The patient and/or his/her parents (or legal representative) refuses to sign the consent
  • It proves impossible to correctly inform the patient and / or his/her parents (or legal representative)
  • The patient has a contra-indication (or an incompatible drug combination) for a treatment required in this study (MEOPA): intracranial hypertension, impaired consciousness, pneumothorax, high rate oxygen-dependence, facial trauma preventing mask application.
  • The patient has a condition that makes hypnosis impossible: e.g. encephalopathy, deafness, communication disorders, does not speak French
  • Suture requiring surgical exploration or an operating room, or general anesthesia or an ears-nose-throat, orthopedic or visceral surgeon (e.g. wound of the oral cavity, abdominal or thoracic penetrating wound, finger or palm wound requiring exploration by an orthopaedist)
  • Fractures associated with wound
  • Use of level II/III analgesics before the beginning of pre-suture care support

Arms & Interventions

Usual care (MEOPA)

Patients randomized to this arm will receive usual care, including MEOPA inhalation during local anesthetic injection and suturing. Intervention: Use of MEOPA during suturing Intervention: Stitch removal

Intervention: Use of MEOPA during suturing

Usual care (MEOPA)

Patients randomized to this arm will receive usual care, including MEOPA inhalation during local anesthetic injection and suturing. Intervention: Use of MEOPA during suturing Intervention: Stitch removal

Intervention: Stitch removal

Experimental arm (Hypnosis)

Patients randomized to this arm will receive usual care as in the other arm, but before MEOPA inhalation is started, hypnosis will be tried. The local anesthetic injection and suturing will therefore take place under hypnosis (and MEOPA if necessary). Intervention: Use of Hypnosis during suturing Intervention: Stitch removal

Intervention: Use of Hypnosis during suturing

Experimental arm (Hypnosis)

Patients randomized to this arm will receive usual care as in the other arm, but before MEOPA inhalation is started, hypnosis will be tried. The local anesthetic injection and suturing will therefore take place under hypnosis (and MEOPA if necessary). Intervention: Use of Hypnosis during suturing Intervention: Stitch removal

Intervention: Stitch removal

Outcomes

Primary Outcomes

Failure of pain control: yes/no

Time Frame: baseline (day 0)

Failure of pain control as defined by: * The conversion of the procedure to MEOPA (for the hypnosis arm) or to sedation (for the MEOPA arm. Conversion is decided if the FLACC score at the end of the induction phase of hypnosis or for MEOPA is greater than 3 (1-3 are equivalent to mild discomfort). * Or a FLACC score\> 3 during the period between anesthetic injection and the end of the suture.

The FLACC score

Time Frame: day 0, during anesthetic injection

Secondary Outcomes

  • The EVENDOL score(day 0, during anesthetic injection)
  • The FLACC scale for pain(during stitch removal (days 6 to 15))
  • MEOPA use(day 0)
  • Qualitative scale for general suturing conditions(day 0)
  • Pain as measured via a VAS score for children over six years of age(day 0, during anesthetic injection)
  • time lapsed between the beginning of the procedure and end of the suture(day 0)
  • Visual analog scale for pain (only for children over 6)(during stitch removal (days 6 to 15))
  • time lapsed between the beginning of the procedure and the beginning of the suture(day 0)
  • Use of physical restraint? yes/no(day 0)
  • Procedure failure: yes/non(day 0)
  • Visual analog scale for operator satisfaction in relation to the performed procedure(day 0)
  • Visual analog scale for operator's perception of the ease of the procedure(day 0)
  • Visual analog scale for parental satisfaction concerning pain care and comfort during suturing(day 0)
  • The EVENDOL scale for pain(during stitch removal (days 6 to 15))
  • Visual analog scale for operator's perception of the ease of stich removal(during stitch removal (days 6 to 15))
  • the child's behaviour during stitch removal(during stitch removal (days 6 to 15))
  • The presence/absence of complications(day 0)

Study Sites (1)

Loading locations...

Similar Trials